Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Fleming

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
The Lancet. Respiratory Medicine|June 16, 2024
Moving forward in IPF: lessons learned from clinical trialsGanesh Raghu, Thomas R Fleming
Lifetime Data Analysis|December 3, 2003
Adaptive test for testing the difference in survival distributionsMonika Pecková, Thomas R Fleming
Journal of Biopharmaceutical Statistics|April 6, 2006
Simultaneous use of weighted logrank and standardized Kaplan-Meier statisticsPeiling Yang, Thomas R Fleming
The New England Journal of Medicine|October 14, 2011
Evaluating rivaroxaban for nonvalvular atrial fibrillation--regulatory considerationsThomas R Fleming, Scott S Emerson
American Journal of Hypertension|June 9, 2019
Cardiovascular Safety Trials of Antidiabetic Therapies to Treat Type 2 Diabetes: Perhaps Asking the Wrong Question?Bruce M Psaty, Thomas R Fleming
Clinical Investigation|February 25, 2014
Noninferiority trials: clinical understandings and misunderstandingsJohn H Powers, Thomas R Fleming
Journal of Biopharmaceutical Statistics|November 9, 2010
Adaptive methods: telling "the rest of the story"Scott S Emerson, Thomas R Fleming
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
Issues in noninferiority trials: the evidence in community-acquired pneumoniaThomas R Fleming, John H Powers
Statistics in Biopharmaceutical Research|November 5, 2013
Adjusting for unknown bias in non-inferiority clinical trialsKatherine Odem-Davis, Thomas R Fleming
Clinical Trials (London, England)|January 16, 2016
Evaluating interventions for Ebola: The need for randomized trialsThomas R Fleming, Susan S Ellenberg
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
The Lancet. Respiratory Medicine|June 16, 2024
Moving forward in IPF: lessons learned from clinical trialsGanesh Raghu, Thomas R Fleming
Lifetime Data Analysis|December 3, 2003
Adaptive test for testing the difference in survival distributionsMonika Pecková, Thomas R Fleming
Journal of Biopharmaceutical Statistics|April 6, 2006
Simultaneous use of weighted logrank and standardized Kaplan-Meier statisticsPeiling Yang, Thomas R Fleming
The New England Journal of Medicine|October 14, 2011
Evaluating rivaroxaban for nonvalvular atrial fibrillation--regulatory considerationsThomas R Fleming, Scott S Emerson
American Journal of Hypertension|June 9, 2019
Cardiovascular Safety Trials of Antidiabetic Therapies to Treat Type 2 Diabetes: Perhaps Asking the Wrong Question?Bruce M Psaty, Thomas R Fleming
Clinical Investigation|February 25, 2014
Noninferiority trials: clinical understandings and misunderstandingsJohn H Powers, Thomas R Fleming
Journal of Biopharmaceutical Statistics|November 9, 2010
Adaptive methods: telling "the rest of the story"Scott S Emerson, Thomas R Fleming
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
Issues in noninferiority trials: the evidence in community-acquired pneumoniaThomas R Fleming, John H Powers
Statistics in Biopharmaceutical Research|November 5, 2013
Adjusting for unknown bias in non-inferiority clinical trialsKatherine Odem-Davis, Thomas R Fleming
Clinical Trials (London, England)|January 16, 2016
Evaluating interventions for Ebola: The need for randomized trialsThomas R Fleming, Susan S Ellenberg
Pageof 11